iPACK Block for Total Knee Arthroplasty
Unknown statusPhase 4NCT06087562
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the rehabilitation process of the Interspace between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) block in total knee arthroplasty.
Study details
- Official title
- Interspace Between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) Block for Postoperative Rehabilitation in Total Knee Arthroplasty: a Randomized Control Trial
- Conditions
- Knee Osteoarthritis
- Knee Pain Chronic
- Knee Disease
- Interventions
- Drug: Ropivacaine 0.5% Injectable Solution 20mL
- Drug: 0,9% normal saline 20mL
- Sponsor
- Poznan University of Medical Sciences
- Start date
- 2020-06-16
- Primary completion
- 2024-09-30
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients \> 18 years old undergoing unilateral total knee arthroplasty Exclusion Criteria: * refusal to participate * \< 18 yo * Chronic opioid use * localized infection
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06087562